
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Ovarian, Fallopian Tube, and Peritoneal Cancer - Gynecology and Obstetrics - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "048ad20d-932a-4cdb-81e9-4c8ea1525476";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1066478";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "162d4b90-6d55-41c2-abd3-16c5150e6d23",
 VasontId : "v1066455"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "b0d75e20-e4c1-4752-bca2-5e83c01332e5",
 VasontId : "v878845"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="048ad20d-932a-4cdb-81e9-4c8ea1525476">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '05d53d16-29c3-42c4-8f90-2671ff9ddfd9';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Ovarian, Fallopian Tube, and Peritoneal Cancer
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/ramirez-pedro.html">Pedro T. Ramirez</a></strong>
 <p class="topic__authors--description">, MD, Houston Methodist Hospital;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/salvo-gloria.html">Gloria Salvo</a></strong>
 <p class="topic__authors--description">, MD, MD Anderson Cancer Center</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Sep 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="183.0;183.8;198.6;233.39" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1066492" class="topicmenu_mobile__paragraph">Etiology</a>
 </li>
 <li>
 <a href="#v1066498" class="topicmenu_mobile__paragraph">Pathology</a>
 </li>
 <li>
 <a href="#v1066550" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1066555" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1066726" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v1066713" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v1066783" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v8544663" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v31323327" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (3)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Types of Ovarian Cancers">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Types of Ovarian Cancers
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"f49a5b3a-6202-4ee3-856f-407f471f3a92","Title":"Types%20of%20Ovarian%20Cancers","ShareUrlTitle":"types-of-ovarian-cancers","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066507","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Types%20of%20Ovarian%20Cancers","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="FIGO Surgical Staging of Ovarian, Fallopian Tube, and Peritoneal Cancer">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 FIGO Surgical Staging of...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"b87e6de1-865e-4673-b5e4-93d4a9fc3c6a","Title":"FIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer","ShareUrlTitle":"figo-surgical-staging-of-ovarian-fallopian-tube-and-peritoneal-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066612","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"FIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Postoperative Treatment of Ovarian Cancer by Stage and Type">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Postoperative Treatment of...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"d198f2e9-26b9-411f-bbdf-e7d1d41cce3a","Title":"Postoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type","ShareUrlTitle":"postoperative-treatment-of-ovarian-cancer-by-stage-and-type","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v68351666","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Postoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1066489" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along with fallopian tube and peritoneal cancers because of shared clinical features. Symptoms are usually absent or nonspecific. Evaluation usually includes ultrasonography, CT or MRI, and measurement of tumor markers (eg, cancer antigen 125). Diagnosis is by histologic analysis. Staging is surgical. Treatment requires hysterectomy, bilateral salpingo-oophorectomy, excision of as much involved tissue as possible (cytoreduction), and usually chemotherapy.</div></p></div><span id="v1066491" class="anchor"></span><div class="para"> <p>In the United States, ovarian cancer is the second most common gynecologic cancer (affecting approximately 1/70 women). It is the fifth leading cause of cancer-related deaths in women and, in the United States, will cause an estimated 19,710 new cases and 13,270 deaths in 2023 (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352425" data-toggle="tooltip" title="General reference" data-id="886769d2-9505-442b-929d-18461eccf9ec" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">1</a><span id="886769d2-9505-442b-929d-18461eccf9ec" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352425"> <span class="tooltip-content"> <span class="tooltip-heading"> General reference </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Incidence is higher in high-resource countries.</p></div> <section id="v68352424" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v68352425" class="anchor"></span> General reference </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058335" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/ovary.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program</a>: Cancer Stat Facts: Ovarian Cancer. Accessed July 14, 2023</p></div></li></ul></div> </div> </section> <section id="v1066492" class="topic__section FHead" itemprop="cause" itemscope="" itemtype="http://schema.org/MedicalCause"> <h2 id="Etiology_v1066493" class="topic__header--section" data-originaltitle="Etiology"> <span id="v1066493" class="anchor"></span> Etiology of Ovarian Cancer </h2> <div class="topic__content"> <span id="v1066494" class="anchor"></span><div class="para"> <p>Ovarian cancer affects mainly perimenopausal and postmenopausal women. Median age at diagnosis is 63 years (range, 55 to 64 years) (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071" data-toggle="tooltip" title="Etiology references" data-id="c65e6b9b-fae0-4a87-afef-d32605984ac8" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">1</a><span id="c65e6b9b-fae0-4a87-afef-d32605984ac8" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v8544606" class="anchor"></span><div class="para"> <p><b>Risk of ovarian cancer is increased</b> by</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323057" class="anchor"></span><div class="para"> <p>A history of ovarian cancer in a 1st-degree relative </p></div></li><li class="topic__listitem"><span id="v8544609" class="anchor"></span><div class="para"> <p>Nulliparity</p></div></li><li class="topic__listitem"><span id="v8544611" class="anchor"></span><div class="para"> <p>Delayed childbearing</p></div></li><li class="topic__listitem"><span id="v8544613" class="anchor"></span><div class="para"> <p>Early menarche</p></div></li><li class="topic__listitem"><span id="v8544615" class="anchor"></span><div class="para"> <p>Delayed menopause</p></div></li><li class="topic__listitem"><span id="v8544617" class="anchor"></span><div class="para"> <p>A personal or family history of endometrial, breast, or colon cancer</p></div></li></ul></div><span id="v8544618" class="anchor"></span><div class="para"> <p><b>Risk is decreased</b> by</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8544621" class="anchor"></span><div class="para"> <p>Oral contraceptive use</p></div></li></ul></div><span id="v1066495" class="anchor"></span><div class="para"> <p>Germline alterations in breast cancer 1 (<i data-mmanualobjecttype='gene' '>BRCA1</i>) and breast cancer 2 (<i data-mmanualobjecttype='gene' '>BRCA2</i>) genes are identified in 14 to 18% of patients with high-grade serous ovarian cancer; 3% have somatic <i data-mmanualobjecttype='gene' '>BRCA</i> mutations (<i data-mmanualobjecttype='gene' '>BRCAm</i>) or inactivation due to methylation (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071" data-toggle="tooltip" title="Etiology references" data-id="dee4f44e-466e-49cb-a3da-62f343e024d0" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">2</a><span id="dee4f44e-466e-49cb-a3da-62f343e024d0" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Deficiency of homologous recombination (which is involved in the repair of DNA damage and replication) is detected in about half of patients with high-grade serous ovarian cancer (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071" data-toggle="tooltip" title="Etiology references" data-id="ac0c126a-523b-41f1-9b44-c7ca4808dfd0" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">3</a><span id="ac0c126a-523b-41f1-9b44-c7ca4808dfd0" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778071"> <span class="tooltip-content"> <span class="tooltip-heading"> Etiology references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v49778058" class="anchor"></span><div class="para"> <p>Mutations in the autosomal dominant <i data-mmanualobjecttype='gene' '>BRCA</i> gene are associated with a 50 to 85% lifetime risk of developing breast cancer. Women with <i data-mmanualobjecttype='gene' '>BRCA1</i> mutations have a 20 to 40% lifetime risk of developing ovarian cancer; risk among women with <i data-mmanualobjecttype='gene' '>BRCA2</i> mutations is 11 to 20%. Incidence of these mutations is higher in people with Ashkenazi Jewish ancestry than in the general population. Mutations in several other genes, including <i data-mmanualobjecttype='gene' '>TP53</i>, <i data-mmanualobjecttype='gene' '>PTEN</i>, <i data-mmanualobjecttype='gene' '>STK11/LKB1</i>, <i data-mmanualobjecttype='gene' '>CDH1</i>, <i data-mmanualobjecttype='gene' '>CHEK2</i>, <i data-mmanualobjecttype='gene' '>ATM</i>, <i data-mmanualobjecttype='gene' '>MLH1</i>, and <i data-mmanualobjecttype='gene' '>MSH2</i>, have been associated with hereditary breast and/or ovarian cancer.</p></div><span id="v1066497" class="anchor"></span><div class="para"> <p>Germ cell cancers usually occur in women aged <span class='symbol'>&lt</span> 30. <a href="./{5EEA5D85-DD75-4FF0-9CE0-8EF532E5C75E}.html" data-toggle="tooltip" title="Male Hypogonadism in Children" data-id="a55b8a77-fed6-4e4d-a0eb-68b2edc1dac3" data-itemid="5eea5d85-dd75-4ff0-9ce0-8ef532e5c75e">XY gonadal dysgenesis</a><span id="a55b8a77-fed6-4e4d-a0eb-68b2edc1dac3" class="d-none xref"> <span class="tooltip-container"> <a href="./{5EEA5D85-DD75-4FF0-9CE0-8EF532E5C75E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Male Hypogonadism in Children </span> Male hypogonadism is decreased production of testosterone, sperm, or both or, rarely, decreased response to testosterone, resulting in delayed puberty, infertility, or both. Diagnosis is by... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> predisposes to ovarian germ cell cancer.</p></div> <section id="v49778070" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalCause"></span> <h3 id="Etiology_v1066493_v49778071" class="topic__header--subsection"> <span itemprop="name" id="v49778071" class="anchor"></span> Etiology references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058339" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/ovary.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program</a>: Cancer Stat Facts: Ovarian Cancer. Accessed July 14, 2023</p></div></li><li class="topic__listitem"><span id="v49778074" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.nature.com/articles/nature10166">Cancer Genome Atlas Research Network</a>: Integrated genomic analyses of ovarian carcinoma. <i>Nature</i> 474 (7353):609–615, 2011. doi: 10.1038/nature10166</p></div></li><li class="topic__listitem"><span id="v49778078" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.nature.com/articles/cr20081">Li X, Heyer WD</a>: Homologous recombination in DNA repair and DNA damage tolerance. <i>Cell Res</i> 18 (1):99–113, 2008. doi: 10.1038/cr.2008.1</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066498" class="topic__section FHead"> <h2 id="Pathology_v1066499" class="topic__header--section" data-originaltitle="Pathology"> <span id="v1066499" class="anchor"></span> Pathology of Ovarian Cancer </h2> <div class="topic__content"> <span id="v1066500" class="anchor"></span><div class="para"> <p>Ovarian cancers are histologically diverse (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"f49a5b3a-6202-4ee3-856f-407f471f3a92","Title":"Types%20of%20Ovarian%20Cancers","ShareUrlTitle":"types-of-ovarian-cancers","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066507","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ETypes%20of%20Ovarian%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>).</p></div><span id="v31323058" class="anchor"></span><div class="para"> <p>Most (90%) ovarian cancers develop from epithelial cells; the rest (germ cell tumors, sex-cord stromal tumors) develop from other ovarian cell types.</p></div><span id="v49778083" class="anchor"></span><div class="para"> <p>Epithelial ovarian carcinoma may be divided into five subtypes:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v49778086" class="anchor"></span><div class="para"> <p>High-grade serous</p></div></li><li class="topic__listitem"><span id="v49778088" class="anchor"></span><div class="para"> <p>Low-grade serous</p></div></li><li class="topic__listitem"><span id="v49778090" class="anchor"></span><div class="para"> <p>Endometrioid</p></div></li><li class="topic__listitem"><span id="v49778092" class="anchor"></span><div class="para"> <p>Clear cell</p></div></li><li class="topic__listitem"><span id="v49778094" class="anchor"></span><div class="para"> <p>Mucinous </p></div></li></ul></div><span id="v49778095" class="anchor"></span><div class="para"> <p>High-grade serous ovarian carcinoma is the most common subtype (> 70%) of epithelial carcinomas and usually manifest at an advanced stage. High-grade serous epithelial ovarian, fallopian tube, and peritoneal carcinomas share clinical behavior and treatment. Most high-grade serous carcinomas that manifest as an ovarian mass or as peritoneal disease originate in the fallopian tubes, based on studies of women with <i data-mmanualobjecttype='gene' '>BRCA</i> mutations after risk-reducing bilateral salpingo-oophorectomy.</p></div><span id="v49778096" class="anchor"></span><div class="para"> <p>Mucinous ovarian cancers are more likely to manifest at stage I than other histologies and account for nearly 27% of patients with stage I epithelial ovarian cancer. </p></div> <span id="v1066504"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1066509"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"f49a5b3a-6202-4ee3-856f-407f471f3a92","Title":"Types%20of%20Ovarian%20Cancers","ShareUrlTitle":"types-of-ovarian-cancers","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066507","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Types%20of%20Ovarian%20Cancers","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="f49a5b3a-6202-4ee3-856f-407f471f3a92"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'f49a5b3a-6202-4ee3-856f-407f471f3a92' }, async: true, success: function (data) { $('#f49a5b3a-6202-4ee3-856f-407f471f3a92').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v1066503" class="anchor"></span><div class="para"> <p>Ovarian cancer spreads by </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323063" class="anchor"></span><div class="para"> <p>Direct extension</p></div></li><li class="topic__listitem"><span id="v31323065" class="anchor"></span><div class="para"> <p>Exfoliation of cells into the peritoneal cavity (peritoneal seeding)</p></div></li><li class="topic__listitem"><span id="v31323067" class="anchor"></span><div class="para"> <p>Lymphatic dissemination to the pelvis and around the aorta</p></div></li><li class="topic__listitem"><span id="v31323069" class="anchor"></span><div class="para"> <p>Less often, hematogenously to the liver or lungs</p></div></li></ul></div> </div> </section> <section id="v1066550" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v1066551" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1066551" class="anchor"></span> Symptoms and Signs of Ovarian Cancer </h2> <div class="topic__content"> <span id="v1066552" class="anchor"></span><div class="para"> <p>Ovarian cancer may be asymptomatic. When symptoms are present, they are nonspecific (eg, dyspepsia, bloating, early satiety, change in bowel habits, urinary frequency). Later, pelvic pain, anemia, cachexia, and abdominal swelling due to ovarian enlargement or ascites usually occur.</p></div><span id="v68352433" class="anchor"></span><div class="para"> <p>An adnexal mass, often solid, irregular, and fixed, may be discovered incidentally. Pelvic and rectovaginal examinations typically detect diffuse nodularity. Few women present with severe abdominal pain secondary to <a href="./{B65BAFE7-27E2-4DA6-8C09-8AA71813643A}.html" data-toggle="tooltip" title="Adnexal Torsion" data-id="786b8186-0f42-40a2-be93-4ea24a0d3fa1" data-itemid="b65bafe7-27e2-4da6-8c09-8aa71813643a">torsion of the ovarian mass</a><span id="786b8186-0f42-40a2-be93-4ea24a0d3fa1" class="d-none xref"> <span class="tooltip-container"> <a href="./{B65BAFE7-27E2-4DA6-8C09-8AA71813643A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Adnexal Torsion </span> Adnexal torsion is twisting of the ovary and sometimes the fallopian tube, interrupting the arterial supply and causing ischemia. Symptoms include severe pelvic pain, often with nausea and vomiting... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.</p></div><span id="v1066554" class="anchor"></span><div class="para"> <p>Germ cell or stromal tumors that produce hormones may have functional effects (eg, hyperthyroidism, feminization, virilization).</p></div> </div> </section> <section id="v1066555" class="topic__section FHead"> <h2 id="Diagnosis_v1066556" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1066556" class="anchor"></span> Diagnosis of Ovarian Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066560" class="anchor"></span><div class="para"> <p>Ultrasonography (for suspected early cancers) or CT or MRI (for suspected advanced cancers)</p></div></li><li class="topic__listitem"><span id="v1066562" class="anchor"></span><div class="para"> <p>Tumor markers (eg, cancer antigen [CA] 125)</p></div></li></ul></div><span id="v1066565" class="anchor"></span><div class="para"> <p>Ovarian cancer is suspected in women with the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066568" class="anchor"></span><div class="para"> <p>Unexplained adnexal masses</p></div></li><li class="topic__listitem"><span id="v1066570" class="anchor"></span><div class="para"> <p>Unexplained abdominal bloating</p></div></li><li class="topic__listitem"><span id="v1066572" class="anchor"></span><div class="para"> <p>Changes in bowel habits</p></div></li><li class="topic__listitem"><span id="v1066574" class="anchor"></span><div class="para"> <p>Unintended weight loss</p></div></li><li class="topic__listitem"><span id="v1066576" class="anchor"></span><div class="para"> <p>Unexplained abdominal pain</p></div></li></ul></div><span id="v1066577" class="anchor"></span><div class="para"> <p>An ovarian mass is more likely to be cancer in postmenopausal women. <a href="./{53075791-FEDF-4B6E-B0BC-FF805EFC732A}.html" data-toggle="tooltip" title="Benign Ovarian Masses" data-id="15d64ac8-d63f-4d58-bdc1-c006ab176a4d" data-itemid="53075791-fedf-4b6e-b0bc-ff805efc732a">Benign functional cysts</a><span id="15d64ac8-d63f-4d58-bdc1-c006ab176a4d" class="d-none xref"> <span class="tooltip-container"> <a href="./{53075791-FEDF-4B6E-B0BC-FF805EFC732A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Benign Ovarian Masses </span> Benign ovarian masses include functional cysts (eg, corpus luteum cysts) and neoplasms (eg, benign teratomas). Most are asymptomatic; some cause pelvic pain. Evaluation includes pelvic examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> can simulate functional germ cell or stromal tumors in reproductive-age women.</p></div><span id="v1066579" class="anchor"></span><div class="para"> <p>A pelvic mass plus ascites usually indicates ovarian cancer but sometimes indicates Meigs syndrome (a benign fibroma with ascites and right hydrothorax).</p></div> <section id="v1066581" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066556_v1066582" class="topic__header--subsection"> <span id="v1066582" class="anchor"></span> Imaging </h3> <div class="topic__content"> <span id="v1066583" class="anchor"></span><div class="para"> <p>If early cancer is suspected, ultrasonography is done first; the following findings suggest cancer:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066586" class="anchor"></span><div class="para"> <p>A solid component</p></div></li><li class="topic__listitem"><span id="v1066588" class="anchor"></span><div class="para"> <p>Surface excrescences</p></div></li><li class="topic__listitem"><span id="v1066590" class="anchor"></span><div class="para"> <p>Size <span class='symbol'>></span> 6 cm</p></div></li><li class="topic__listitem"><span id="v1066592" class="anchor"></span><div class="para"> <p>Irregular shape</p></div></li><li class="topic__listitem"><span id="v1066594" class="anchor"></span><div class="para"> <p>Low vascular resistance detected by transvaginal Doppler flow studies</p></div></li></ul></div><span id="v1066595" class="anchor"></span><div class="para"> <p>If advanced cancer is suspected (eg, based on ascites, abdominal distention, or nodularity or fixation detected during physical examination), CT or MRI is usually done before surgery to determine extent of the cancer.</p></div> </div> </section> <section id="v1066596" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066556_v1066597" class="topic__header--subsection"> <span id="v1066597" class="anchor"></span> Tumor markers </h3> <div class="topic__content"> <span id="v1066598" class="anchor"></span><div class="para"> <p>Tumor markers for nonepithelial tumors (eg, germ cell tumors, stromal tumors) include the beta subunit of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>human chorionic gonadotropin</span> (beta-hCG), lactic dehydrogenase (LDH), alpha-fetoprotein, and inhibin; they are typically measured in young patients, who are at higher risk of these cancers. CA 125 is also measured. In perimenopausal and postmenopausal patients, only CA 125 is measured because most ovarian cancers in this age group are epithelial tumors. CA 125 is elevated in 80% of advanced epithelial ovarian cancers but may be within normal range in early stages. It may also be mildly elevated in endometriosis, pelvic inflammatory disease, pregnancy, fibroids, peritoneal inflammation, or nonovarian peritoneal cancer.</p></div><span id="v31323073" class="anchor"></span><div class="para"> <p>A mixed solid and cystic pelvic mass in postmenopausal women, especially if CA 125 is elevated, raises suspicion of ovarian cancer.</p></div> </div> </section> <section id="v1066600" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066556_v1066601" class="topic__header--subsection"> <span id="v1066601" class="anchor"></span> Histology </h3> <div class="topic__content"> <span id="v1066602" class="anchor"></span><div class="para"> <p>A biopsy is not routinely recommended unless a patient is not a surgical candidate, because it may cause leakage of cells and upstaging of the cancer. Rarely, when biopsy is done, samples are obtained by needle biopsy for masses or by needle aspiration for ascitic fluid.</p></div><span id="v1066603" class="anchor"></span><div class="para"> <p>For masses that appear benign on ultrasonography, ultrasonography is repeated after 6 weeks and then every 3 to 6 months until it confirms that no malignant features are developing. Such benign-appearing masses include benign cystic teratomas (dermoid cysts), follicular cysts, and endometriomas. Masses that are indeterminate may require exploratory surgery and unilateral salpingo-oophorectomy to confirm histology.</p></div> </div> </section> <section id="v1066604" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1066556_v1066605" class="topic__header--subsection"> <span id="v1066605" class="anchor"></span> Staging </h3> <div class="topic__content"> <span id="v1066606" class="anchor"></span><div class="para"> <p>Ovarian cancer is staged surgically (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"b87e6de1-865e-4673-b5e4-93d4a9fc3c6a","Title":"FIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer","ShareUrlTitle":"figo-surgical-staging-of-ovarian-fallopian-tube-and-peritoneal-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066612","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EFIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>).</p></div> <span id="v1066609"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1066614"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"b87e6de1-865e-4673-b5e4-93d4a9fc3c6a","Title":"FIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer","ShareUrlTitle":"figo-surgical-staging-of-ovarian-fallopian-tube-and-peritoneal-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v1066612","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"FIGO%20Surgical%20Staging%20of%20Ovarian%2C%20Fallopian%20Tube%2C%20and%20Peritoneal%20Cancer","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="b87e6de1-865e-4673-b5e4-93d4a9fc3c6a"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'b87e6de1-865e-4673-b5e4-93d4a9fc3c6a' }, async: true, success: function (data) { $('#b87e6de1-865e-4673-b5e4-93d4a9fc3c6a').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v1607966" class="anchor"></span><div class="para"> <p>If early-stage cancer is suspected, staging may be done by laparoscopy or robotic-assisted laparoscopic surgery. Otherwise, an abdominal midline incision that allows adequate access to the upper abdomen is required. </p></div><span id="v68352436" class="anchor"></span><div class="para"> <p>The <b>staging procedure</b> includes hysterectomy and bilateral salpingo-oophorectomy. All peritoneal surfaces, hemidiaphragms, and abdominal and pelvic viscera are inspected and palpated. Washings from the pelvis, abdominal gutters, and diaphragmatic recesses are obtained, and multiple biopsies of the peritoneum in the central and lateral pelvis and in the abdomen are done. For early-stage cancer, the infracolic omentum is removed, and pelvic and para-aortic lymph nodes are sampled. Sentinel lymph node biopsy is not routinely done in patients with ovarian cancer. </p></div><span id="v1066608" class="anchor"></span><div class="para"> <p>Cancers are also graded histologically, and epithelial ovarian cancers are classified as low-grade (grade 1) or high-grade (grade 2 or 3).</p></div> </div> </section> </div> </section> <section id="v1066726" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1066727" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1066727" class="anchor"></span> Treatment of Ovarian Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066731" class="anchor"></span><div class="para"> <p>Usually hysterectomy and bilateral salpingo-oophorectomy</p></div></li><li class="topic__listitem"><span id="v31323137" class="anchor"></span><div class="para"> <p>Cytoreductive surgery</p></div></li><li class="topic__listitem"><span id="v1066733" class="anchor"></span><div class="para"> <p>Usually postoperative chemotherapy, often with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></li></ul></div><span id="v49778107" class="anchor"></span><div class="para"> <p>(See also <a rel="nofollow" target="_blank" href="https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf">National Comprehensive Cancer Network (NCCN)</a>: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer.)</p></div><span id="v68352437" class="anchor"></span><div class="para"> <p>Treatment of ovarian, fallopian tube, and peritoneal cancer is based on stage, grade, and histology:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352440" class="anchor"></span><div class="para"> <p>For stage IA or IB ovarian tumors (confined to the ovary) and/or grade 1 endometrioid tumors, prognosis is excellent (survival 90%) after surgery alone.</p></div></li><li class="topic__listitem"><span id="v68352442" class="anchor"></span><div class="para"> <p>For patients with stage IC, II, grade 3, or clear cell histology, adjuvant chemotherapy treatment (eg, with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>) is recommended.</p></div></li><li class="topic__listitem"><span id="v68352444" class="anchor"></span><div class="para"> <p>For stage III or IV, primary surgical cytoreduction followed by systemic chemotherapy is the standard treatment. Neoadjuvant chemotherapy followed by cytoreductive surgery is the preferred option for patients who are not candidates for surgical resection (due to location and volume of the cancer or because of comorbidities).</p></div></li></ul></div><span id="v49778109" class="anchor"></span><div class="para"> <p>Hysterectomy and bilateral salpingo-oophorectomy are usually indicated, but fertility preservation by conserving the unaffected ovary and uterus may be considered for stage I nonepithelial or low-grade unilateral epithelial ovarian cancers in young patients.</p></div><span id="v42291419" class="anchor"></span><div class="para"> <p>Potential indications for neoadjuvant chemotherapy include one or more of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8544644" class="anchor"></span><div class="para"> <p>Multiple liver metastases</p></div></li><li class="topic__listitem"><span id="v8544646" class="anchor"></span><div class="para"> <p>Lymphadenopathy in the porta hepatis</p></div></li><li class="topic__listitem"><span id="v8544648" class="anchor"></span><div class="para"> <p>Suprarenal para-aortic lymph nodes</p></div></li><li class="topic__listitem"><span id="v8544650" class="anchor"></span><div class="para"> <p>Diffuse mesenteric disease</p></div></li><li class="topic__listitem"><span id="v8544652" class="anchor"></span><div class="para"> <p>Evidence of pleural or parenchymal lung disease</p></div></li></ul></div><span id="v68352445" class="anchor"></span><div class="para"> <p>In a large randomized trial, neoadjuvant chemotherapy followed by surgery had less perioperative morbidity than primary surgery followed by chemotherapy and similar long-term survival rates (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="d3cd02a1-b7f5-4efb-9a24-16778ed13265" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">1</a><span id="d3cd02a1-b7f5-4efb-9a24-16778ed13265" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> <section id="v31323153" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066727_v31323154" class="topic__header--subsection"> <span id="v31323154" class="anchor"></span> Surgical staging and cytoreduction </h3> <div class="topic__content"> <span id="v68352447" class="anchor"></span><div class="para"> <p>The surgical procedure for ovarian, fallopian tube, and peritoneal cancers includes staging and cytoreduction (all visibly involved tissue is surgically removed if possible). Cytoreduction is associated with increased survival time; the volume of residual disease remaining after cytoreduction correlates inversely with survival time.</p></div><span id="v68352448" class="anchor"></span><div class="para"> <p>Cytoreductive surgery for ovarian cancer usually includes </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352451" class="anchor"></span><div class="para"> <p>Supracolic omentectomy, sometimes with rectosigmoid resection (usually with primary reanastomosis)</p></div></li><li class="topic__listitem"><span id="v68352453" class="anchor"></span><div class="para"> <p>Radical peritoneal stripping</p></div></li><li class="topic__listitem"><span id="v68352455" class="anchor"></span><div class="para"> <p>Resection of diaphragmatic peritoneum or splenectomy</p></div></li></ul></div><span id="v68352456" class="anchor"></span><div class="para"> <p>Cytoreduction may be</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352459" class="anchor"></span><div class="para"> <p>Complete: Cytoreduction to no grossly visible disease</p></div></li><li class="topic__listitem"><span id="v68352461" class="anchor"></span><div class="para"> <p>Optimal: Cytoreduction with residual disease that is ≤ 1 cm in maximum tumor diameter, as defined by the Gynecologic Oncology Group</p></div></li><li class="topic__listitem"><span id="v68352463" class="anchor"></span><div class="para"> <p>Suboptimal: Cytoreduction with any visible tumor nodules > 1 cm remaining</p></div></li></ul></div><span id="v31323155" class="anchor"></span><div class="para"> <p>Because cytoreduction is associated with increased survival, being able to predict when cytoreduction to no gross residual disease can be done is important, but doing so is difficult; there are no uniform criteria.</p></div><span id="v31323156" class="anchor"></span><div class="para"> <p>Optimal cytoreduction is less likely if patients have the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323159" class="anchor"></span><div class="para"> <p>Poor performance status</p></div></li><li class="topic__listitem"><span id="v31323161" class="anchor"></span><div class="para"> <p>Age > 60 years</p></div></li><li class="topic__listitem"><span id="v31323163" class="anchor"></span><div class="para"> <p>American Society of Anesthesiologists physical status 3 or 4</p></div></li><li class="topic__listitem"><span id="v31323165" class="anchor"></span><div class="para"> <p>Medical comorbidities</p></div></li><li class="topic__listitem"><span id="v31323167" class="anchor"></span><div class="para"> <p>Poor nutritional status</p></div></li><li class="topic__listitem"><span id="v31323169" class="anchor"></span><div class="para"> <p>Extra-abdominal disease</p></div></li><li class="topic__listitem"><span id="v31323171" class="anchor"></span><div class="para"> <p>Large tumor bulk</p></div></li><li class="topic__listitem"><span id="v31323173" class="anchor"></span><div class="para"> <p>Involvement of large bowel</p></div></li><li class="topic__listitem"><span id="v31323175" class="anchor"></span><div class="para"> <p>Metastases to retroperitoneal lymph nodes above the renal vessels and > 1 cm in largest dimension</p></div></li><li class="topic__listitem"><span id="v31323177" class="anchor"></span><div class="para"> <p>Parenchymal liver involvement</p></div></li><li class="topic__listitem"><span id="v31323179" class="anchor"></span><div class="para"> <p>A preoperative CA 125 > 500 U/mL</p></div></li></ul></div><span id="v68352464" class="anchor"></span><div class="para"> <p>The Fagotti score, based on seven laparoscopic findings, can help predict the likelihood of optimal cytoreduction in patients with advanced ovarian cancer. This scoring system assigns a value of 0 or 2 depending on whether disease is present in certain locations. If patients score ≥ 10, optimal cytoreduction is very unlikely. If they score < 10, they are considered candidates for cytoreductive surgery (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="c9552607-0a36-413f-838b-2afc311639c3" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">2</a><span id="c9552607-0a36-413f-838b-2afc311639c3" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v31323181" class="anchor"></span><div class="para"> <p>Diagnostic laparoscopy before laparotomy can spare patients an unnecessary laparotomy, which would result in suboptimal cytoreduction. Laparoscopy enables clinicians to do a tissue biopsy, make a definitive diagnosis, and analyze the biopsy sample. Thus, patients who are not candidates for cytoreduction can begin chemotherapy treatment earlier. Laparoscopic findings indicating that optimal cytoreduction is unlikely include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323184" class="anchor"></span><div class="para"> <p>Omental cake</p></div></li><li class="topic__listitem"><span id="v31323186" class="anchor"></span><div class="para"> <p>Extensive peritoneal or diaphragmatic carcinomatosis</p></div></li><li class="topic__listitem"><span id="v31323188" class="anchor"></span><div class="para"> <p>Mesenteric retraction</p></div></li><li class="topic__listitem"><span id="v31323190" class="anchor"></span><div class="para"> <p>Bowel and stomach infiltration</p></div></li><li class="topic__listitem"><span id="v31323192" class="anchor"></span><div class="para"> <p>Spleen and/or liver superficial metastasis</p></div></li></ul></div> </div> </section> <section id="v68352467" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066727_v68352468" class="topic__header--subsection"> <span id="v68352468" class="anchor"></span> Systemic or intraperitoneal chemotherapy </h3> <div class="topic__content"> <span id="v68352469" class="anchor"></span><div class="para"> <p>In most patients with newly diagnosed ovarian cancer, the disease has spread widely throughout the peritoneum; thus, treatment involves one of the following (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"d198f2e9-26b9-411f-bbdf-e7d1d41cce3a","Title":"Postoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type","ShareUrlTitle":"postoperative-treatment-of-ovarian-cancer-by-stage-and-type","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v68351666","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EPostoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>):</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352473" class="anchor"></span><div class="para"> <p>Staging and cytoreduction, followed by 6 cycles of IV chemotherapy</p></div></li><li class="topic__listitem"><span id="v68352475" class="anchor"></span><div class="para"> <p>3 cycles of neoadjuvant chemotherapy, followed by surgery and 3 more chemotherapy cycles</p></div></li></ul></div><span id="v68352476" class="anchor"></span><div class="para"> <p>Standard chemotherapy is 6 courses of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>. Other agents may be used depending on patient and tumor characteristics.</p></div><span id="v68352477" class="anchor"></span><div class="para"> <p>For certain patients at higher risk of recurrence (eg, those who have pleural effusions or ascites and do not have a <i data-mmanualobjecttype='gene' '>BRCA</i> mutation), adding <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span> to chemotherapy and continuing it as maintenance therapy is an option.</p></div><span id="v84058344" class="anchor"></span><div class="para"> <p>Primary therapy for patients newly diagnosed with stage IIB-IV epithelial ovarian, fallopian tube, or peritoneal cancer who undergo primary cytoreductive surgery is 6 cycles of chemotherapy (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>) plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bevacizumab</span> therapy for 15 months is the standard of care, based on a multicenter randomized open-label phase III trial that found no difference in progression-free survival or overall survival in patients treated for 15 versus 30 months (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="11b70661-5b20-4e9c-9c1d-c941dd0e340c" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">3</a><span id="11b70661-5b20-4e9c-9c1d-c941dd0e340c" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352479" class="anchor"></span><div class="para"> <p>PARP (polyadenosine diphosphate-ribose polymerase) enzymes are essential to the repair of single-strand breaks in DNA. Inhibition of PARP enzymes leads to persistent single-strand breaks, which cause double-strand breaks to accumulate during DNA replication and ultimately lead to tumor cell death.</p></div><span id="v68352480" class="anchor"></span><div class="para"> <p>In several clinical trials, a PARP inhibitor (PARPi) after chemotherapy improved progression-free survival in women who have serous or high-grade endometrioid ovarian cancer and who completed first-line chemotherapy, even if they did not have a <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutation (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="ba582621-10f9-4e27-8357-6dde0f830267" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">4</a><span id="ba582621-10f9-4e27-8357-6dde0f830267" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="bcec073f-2359-455d-a238-4d430fce1f49" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">5</a><span id="bcec073f-2359-455d-a238-4d430fce1f49" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="1524ba59-e99c-4686-9bb1-375c3d46865f" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">6</a><span id="1524ba59-e99c-4686-9bb1-375c3d46865f" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="47e59f50-ca8c-4cc4-badb-16883ba9c441" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">7</a><span id="47e59f50-ca8c-4cc4-badb-16883ba9c441" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352487" class="anchor"></span><div class="para"> <p>Two placebo-controlled studies evaluated maintenance therapy with a PARPi in patients who responded to first-line platinum therapy. The SOLO1 study evaluated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> in patients with somatic and germline <i data-mmanualobjecttype='gene' '>BRCAm</i> (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="7035c656-cf58-4a4a-9286-044da5bf8f5d" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">8</a><span id="7035c656-cf58-4a4a-9286-044da5bf8f5d" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), and the PRIMA/ENGOT-Ov26 study evaluated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niraparib</span> in patients with newly diagnosed advanced ovarian cancer (not restricted to <i data-mmanualobjecttype='gene' '>BRCAm</i> carriers [ <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="4b01043d-9c56-46a1-a562-c769409c21fa" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">5</a><span id="4b01043d-9c56-46a1-a562-c769409c21fa" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]).</p></div><span id="v84058346" class="anchor"></span><div class="para"> <p>An international randomized double-blind phase III trial (PAOLA-1) in newly diagnosed advanced, high-grade ovarian cancer evaluated the addition of maintenance <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> (a PARPi) following response to first-line platinum–taxane chemotherapy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>. Patients were included regardless of surgical outcome or <i data-mmanualobjecttype='gene' '>BRCA</i> mutation status. The addition of maintenance <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> provided a significant progression-free survival benefit, which was substantial in patients with homologous recombination deficiency (HRD)–positive tumors, including those without a <i data-mmanualobjecttype='gene' '>BRCA</i> mutation (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="bab7e137-fb52-4837-826b-16f0672206f1" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">9</a><span id="bab7e137-fb52-4837-826b-16f0672206f1" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352492" class="anchor"></span><div class="para"> <p>The VELIA trial included patients with previously untreated stage III or IV high-grade serous ovarian carcinoma. This three-arm trial compared standard chemotherapy alone versus standard chemotherapy plus veliparib versus standard chemotherapy plus veliparib followed by maintenance therapy with veliparib (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="eba300f2-33a8-4d23-a6e9-958c56ed047b" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">4</a><span id="eba300f2-33a8-4d23-a6e9-958c56ed047b" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Progression-free survival was longest with veliparib chemotherapy plus veliparib maintenance therapy.</p></div><span id="v68352494" class="anchor"></span><div class="para"> <p>Intraperitoneal chemotherapy using a catheter has been suggested as an alternative to IV chemotherapy. Intraperitoneal chemotherapy delivers the agents directly to the peritoneal surface and thus eliminates residual microscopic disease. In advanced-stage ovarian cancer, combination treatment with IV and intraperitoneal chemotherapy appears to prolong overall survival after primary cytoreductive surgery (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="bdee3981-49d3-41e6-b1a5-f2be01a5c731" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">10</a><span id="bdee3981-49d3-41e6-b1a5-f2be01a5c731" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). This approach is not without complications; catheter-related complications can limit its use (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="e9b8bcb9-caed-4e6e-92f7-e8fbbd7bd17b" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">11</a><span id="e9b8bcb9-caed-4e6e-92f7-e8fbbd7bd17b" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352497" class="anchor"></span><div class="para"> <p>Direct delivery of chemotherapy to the abdominal cavity under hyperthermic conditions (HIPEC) intraoperatively after cytoreduction has been used in patients with colon cancer and is under study for ovarian cancer. The potential benefit of HIPEC is increased sensitivity to chemotherapy by impairing DNA repair, it induces apoptosis and activates heat-shock proteins.</p></div> <span id="v68351665"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v68351667"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"d198f2e9-26b9-411f-bbdf-e7d1d41cce3a","Title":"Postoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type","ShareUrlTitle":"postoperative-treatment-of-ovarian-cancer-by-stage-and-type","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v68351666","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Postoperative%20Treatment%20of%20Ovarian%20Cancer%20by%20Stage%20and%20Type","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="d198f2e9-26b9-411f-bbdf-e7d1d41cce3a"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'd198f2e9-26b9-411f-bbdf-e7d1d41cce3a' }, async: true, success: function (data) { $('#d198f2e9-26b9-411f-bbdf-e7d1d41cce3a').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v68352499" class="anchor"></span><div class="para"> <p>Even if chemotherapy results in a complete clinical response (ie, normal physical examination, normal serum CA 125, negative CT scan of the abdomen and pelvis), approximately 50% of patients with stage III or IV cancer have residual tumor. Of patients with persistent elevation of CA 125, 90 to 95% have residual tumor.</p></div> </div> </section> <section id="v49778143" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066727_v49778144" class="topic__header--subsection"> <span id="v49778144" class="anchor"></span> Recurrent disease </h3> <div class="topic__content"> <span id="v49778145" class="anchor"></span><div class="para"> <p>Recurrence of ovarian cancer can be detected serologically with tumor markers (eg, CA 125) and/or by radiologic signs of progression. Treatment of recurrence depends on the time between the completion of platinum-based treatment and detection of recurrence (platinum-free interval [PFI]):</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v49778148" class="anchor"></span><div class="para"> <p>A PFI of ≥ 6 months suggests platinum-sensitive disease.</p></div></li><li class="topic__listitem"><span id="v49778150" class="anchor"></span><div class="para"> <p>A PFI of < 6 months suggests platinum-resistant disease.</p></div></li></ul></div><span id="v49778151" class="anchor"></span><div class="para"> <p>The main treatment for patients with recurrent ovarian cancer has been systemic therapy. If cancer recurs or progresses after effective chemotherapy, chemotherapy is restarted. Useful drugs for ovarian cancer may include liposomal <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxorubicin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>docetaxel</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>gemcitabine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>, and a combination of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cyclophosphamide</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span> or of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>gemcitabine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span> (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="754ef054-189f-4c13-ae85-e6c064269a7f" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">12</a><span id="754ef054-189f-4c13-ae85-e6c064269a7f" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Targeted therapy with biologic agents is under study.</p></div><span id="v49778152" class="anchor"></span><div class="para"> <p>If platinum-sensitive ovarian cancer recurs, a PARP inhibitor—<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>niraparib</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rucaparib</span>—is used for maintenance therapy (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="3bacf937-4337-4c12-8325-386a0903ab6d" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">13</a><span id="3bacf937-4337-4c12-8325-386a0903ab6d" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="42489f51-1255-4b73-999b-005b03a86557" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">14</a><span id="42489f51-1255-4b73-999b-005b03a86557" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v84058350" class="anchor"></span><div class="para"> <p>For patients with recurrent high-grade serous or endometrioid ovarian cancer with platinum-sensitive tumors and who had a <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutation, a randomized double-blind placebo-controlled phase III trial (SOLO2/ENGOT-Ov21) found that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> compared with placebo resulted in increased progression-free survival. Although statistical significance was not reached for overall survival (OS), patients treated with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> had a median 12.9-month increase in OS compared with placebo, which may also support use of maintenance <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> in these patients (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156" data-toggle="tooltip" title="Treatment references" data-id="2410bba5-ebe7-434d-9d9d-627fa60774f7" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">15</a><span id="2410bba5-ebe7-434d-9d9d-627fa60774f7" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352502" class="anchor"></span><div class="para"> <p>Randomized trials of secondary cytoreductive surgery in patients with platinum-sensitive ovarian cancer have had variable results. Several trials compared surgical cytoreduction followed by chemotherapy versus chemotherapy alone, In one trial (GOG-0213), overall survival time did not increase, but in other trials, there were significant increases in overall survival time (in DESKTOP III, 53.7 versus 46.0 months) or progression-free survival time (in SOC-1, 17.4 versus 11.9 months [ <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="2e77dfa3-e1fb-45f0-9f7f-d34c72c557c7" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">16</a><span id="2e77dfa3-e1fb-45f0-9f7f-d34c72c557c7" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="92145c47-c7a8-42c9-81da-69fdad1fc205" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">17</a><span id="92145c47-c7a8-42c9-81da-69fdad1fc205" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156" data-toggle="tooltip" title="Treatment references" data-id="fc5b11db-f066-4d71-9195-a8efba8af65d" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">18</a><span id="fc5b11db-f066-4d71-9195-a8efba8af65d" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v49778156"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>]).</p></div> </div> </section> <section id="v49778155" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1066727_v49778156" class="topic__header--subsection"> <span itemprop="name" id="v49778156" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68352507" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/10.1056/NEJMoa0908806?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov">Vergote I, Tropé CG, Amant F, et al</a>; Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. <i>N Engl J Med</i> 2010;363 (10):943–953, 2010. doi:10.1056/ NEJMoa0908806</p></div></li><li class="topic__listitem"><span id="v49778159" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.gynecologiconcology-online.net/article/S0090-8258(15)30080-9/fulltext">Petrillo M, Vizzielli G, Fanfani F, et al</a>: Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept. <i>Gynecol Oncol</i> 139 (1):5–9, 2015. doi:10.1016/j.ygyno.2015.07.095 Epub 2015 Jul 18.</p></div></li><li class="topic__listitem"><span id="v84058355" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36332161/">Pfisterer J, Joly F, Kristensen G, et al</a>. Optimal Treatment Duration of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bevacizumab</span> as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. <i>J Clin Oncol</i> 41(4):893-902, 2023. doi:10.1200/JCO.22.01010</p></div></li><li class="topic__listitem"><span id="v49778163" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1909707">Coleman RL, Fleming GF, Brady MF, et al</a>: Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. <span class="genericDrug" data-showrollover="false">N Engl J Med</span> 381 (25):2403–2415, 2019. doi: 10.1056/NEJMoa1909707 Epub 2019 Sep 28.</p></div></li><li class="topic__listitem"><span id="v49778167" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">González-Martín A, Pothuri B, Vergote I, et al</a>: <span class="genericDrug" data-showrollover="false">Niraparib</span> in patients with newly diagnosed advanced ovarian cancer. <i>N Engl J Med</i> 381 (25):2391–2402, 2019. doi: 10.1056/NEJMoa1910962 Epub 2019 Sep 28.</p></div></li><li class="topic__listitem"><span id="v49778171" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1911361?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Ray-Coquard I, Pautier P, Pignata S, et al</a>: <span class="genericDrug" data-showrollover="false">Olaparib</span> plus <span class="genericDrug" data-showrollover="false">bevacizumab</span> as first-line maintenance in ovarian cancer. <i>N Engl J Med</i> 381 (25):2416–2428, 2019. doi: 10.1056/NEJMoa1911361</p></div></li><li class="topic__listitem"><span id="v49778175" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1810858?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Moore K, Colombo N, Scambia G, et al</a>: Maintenance <span class="genericDrug" data-showrollover="false">olaparib</span> in patients with newly diagnosed advanced ovarian cancer. <i>N Engl J Med</i> 379 (26):2495–2505, 2018. doi: 10.1056/NEJMoa1810858 Epub 2018 Oct 21.</p></div></li><li class="topic__listitem"><span id="v68352511" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00531-3/fulltext">Banerjee S, Moore KN, Colombo N, et al</a>: Maintenance <span class="genericDrug" data-showrollover="false">olaparib</span> for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial. <i>Lancet Oncol</i> 22 (12):1721–1731, 2021. doi: 10.1016/S1470-2045(21)00531-3 Epub 2021 Oct 26</p></div></li><li class="topic__listitem"><span id="v84058364" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31851799/">Ray-Coquard I, Pautier P, Pignata S, et al</a>: <span class="genericDrug" data-showrollover="false">Olaparib</span> plus <span class="genericDrug" data-showrollover="false">Bevacizumab</span> as First-Line Maintenance in Ovarian Cancer. <i>N Engl J Med</i> 381(25):2416-2428, 2019. doi:10.1056/NEJMoa1911361</p></div></li><li class="topic__listitem"><span id="v68352515" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/10.1056/NEJMoa052985?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov">Armstrong DK, Bundy B, Wenzel L, et al</a>: Intraperitoneal <span class="genericDrug" data-showrollover="false">cisplatin</span> and <span class="genericDrug" data-showrollover="false">paclitaxelin</span> in ovarian cancer. <i>N Engl J Med</i> 354:34–43, 2006. doi: 10.1056/NEJMoa052985</p></div></li><li class="topic__listitem"><span id="v68352519" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://ascopubs.org/doi/10.1200/JCO.2015.61.4776?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Wright AA, Cronin A, Milne DE, et al</a>: Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer. <i>J Clin Oncol</i> 33:2841–2847, 2015. doi: 10.1200/JCO.2015.61.4776</p></div></li><li class="topic__listitem"><span id="v68352523" class="anchor"></span><div class="para"> <p>12. <a rel="nofollow" target="_blank" href="https://jamanetwork.com/journals/jamaoncology/fullarticle/2773114">Zsiros E, Lynam S, Attwood KM, et al</a>: Efficacy and safety of <span class="genericDrug" data-showrollover="false">pembrolizumab</span> in combination with <span class="genericDrug" data-showrollover="false">bevacizumab</span> and oral metronomic <span class="genericDrug" data-showrollover="false">cyclophosphamide</span> in the treatment of recurrent ovarian cancer: A phase 2 nonrandomized clinical trial. <i>JAMA Oncol</i> 7 (1):78–85, 2021. doi: 10.1001/jamaoncol.2020.5945</p></div></li><li class="topic__listitem"><span id="v49778179" class="anchor"></span><div class="para"> <p>13. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1105535?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Ledermann J, Harter P, Gourley C, et al</a>: <span class="genericDrug" data-showrollover="false">Olaparib</span> maintenance therapy in platinum-sensitive relapsed ovarian cancer. <i>N Engl J Med</i> 366 (15):1382–1392, 2012. doi: 10.1056/NEJMoa1105535 Epub 2012 Mar 27.</p></div></li><li class="topic__listitem"><span id="v49778183" class="anchor"></span><div class="para"> <p>14. <a rel="nofollow" target="_blank" href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30469-2/fulltext">Pujade-Lauraine E, Ledermann JA, Selle F, et al</a>: <span class="genericDrug" data-showrollover="false">Olaparib</span> tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): A double-blind, randomised, placebo-controlled, phase 3 trial. <i>Lancet Oncol</i> 18 (9):1274–1284, 2017. doi: 10.1016/S1470-2045(17)30469-2 Epub 2017 Jul 25.</p></div></li><li class="topic__listitem"><span id="v84058376" class="anchor"></span><div class="para"> <p>15. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33743851/">Poveda A, Floquet A, Ledermann JA, et al</a>: <span class="genericDrug" data-showrollover="false">Olaparib</span> tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. <i>Lancet Oncol</i> 22(5):620-631, 2021. doi:10.1016/S1470-2045(21)00073-5</p></div></li><li class="topic__listitem"><span id="v68352527" class="anchor"></span><div class="para"> <p>16. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/full/10.1056/nejmoa1902626">Coleman RL, Spirtos NM, Enserro D, et al</a>: Secondary surgical cytoreduction for recurrent ovarian cancer. <i>N Engl J Med</i> 381 (20):1929–1939, 2019. doi: 10.1056/NEJMoa1902626</p></div></li><li class="topic__listitem"><span id="v68352531" class="anchor"></span><div class="para"> <p>17. <a rel="nofollow" target="_blank" href="https://www.nejm.org/doi/10.1056/NEJMoa2103294?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed">Harter P, Sehouli J, Vergote I, et al</a>: Randomized trial of cytoreductive surgery for relapsed ovarian cancer. <i>N Engl J Med</i> 385 (23):2123–2131, 2021. doi: 10.1056/NEJMoa2103294</p></div></li><li class="topic__listitem"><span id="v68352535" class="anchor"></span><div class="para"> <p>18. <a rel="nofollow" target="_blank" href="https://www.sciencedirect.com/science/article/abs/pii/S1470204521000061?via%3Dihub">Shi T, Zhu J, Feng Y, et al</a>: Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): A multicentre, open-label, randomised, phase 3 trial. <i>Lancet Onco</i>l 22 (4):439–449, 2021. doi: 10.1016/S1470-2045(21)00006-1 Epub 2021 Mar 8.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066713" class="topic__section FHead"> <h2 id="Prognosis_v1066714" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v1066714" class="anchor"></span> Prognosis for Ovarian Cancer </h2> <div class="topic__content"> <span id="v1066715" class="anchor"></span><div class="para"> <p>In women with ovarian cancer, the 5-year survival rates with treatment are (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v84058382" data-toggle="tooltip" title="Prognosis references" data-id="9e5a8fd9-cbf6-41d0-a324-f49e931f69da" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">1</a><span id="9e5a8fd9-cbf6-41d0-a324-f49e931f69da" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v84058382"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>)</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066718" class="anchor"></span><div class="para"> <p>Stage I: 85 to 95%</p></div></li><li class="topic__listitem"><span id="v1066720" class="anchor"></span><div class="para"> <p>Stage II: 70 to 78%</p></div></li><li class="topic__listitem"><span id="v1066722" class="anchor"></span><div class="para"> <p>Stage III: 40 to 60%</p></div></li><li class="topic__listitem"><span id="v1066724" class="anchor"></span><div class="para"> <p>Stage IV: 15 to 20%</p></div></li></ul></div><span id="v1066725" class="anchor"></span><div class="para"> <p>Prognosis is worse when tumor grade is higher or when surgery cannot remove all visibly involved tissue; in such cases, prognosis is best when the involved tissue can be reduced to <span class='symbol'>&lt</span> 1 cm in diameter or ideally to a microscopic residual amount (cytoreductive surgery).</p></div><span id="v31323135" class="anchor"></span><div class="para"> <p>With stage III or IV ovarian cancer, recurrence rate is approximately 70% (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v84058382" data-toggle="tooltip" title="Prognosis references" data-id="a639c5e3-52d5-447e-928c-9bdb0eef800d" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">2</a><span id="a639c5e3-52d5-447e-928c-9bdb0eef800d" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v84058382"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> <section id="v84058381" class="topic__section GHead"> <span></span> <h3 id="Prognosis_v1066714_v84058382" class="topic__header--subsection"> <span id="v84058382" class="anchor"></span> Prognosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058385" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/ovary.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program</a>: Cancer Stat Facts: Ovarian Cancer. Accessed August 31, 2023</p></div></li><li class="topic__listitem"><span id="v84058388" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737875/">Kurnit KC, Fleming GF, Lengyel E</a>: Updates and new options in advanced epithelial ovarian cancer treatment. <i>Obstet Gynecol</i> 137(1):108-121, 2021. doi:10.1097/AOG.0000000000004173</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066783" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Prevention_v1066784" class="topic__header--section" data-originaltitle="Prevention"> <span id="v1066784" class="anchor"></span> Prevention of Ovarian Cancer </h2> <div class="topic__content"> <span id="v84058390" class="anchor"></span><div class="para"> <p>Estrogen-progestin contraceptive use is associated with a decreased risk of ovarian cancer; in average-risk patients, risk is decreased by approximately 50% after 5 years of use and 80% after ≥ 10 years of use (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574" data-toggle="tooltip" title="Prevention references" data-id="df051637-4f2d-4d6c-a1f6-323bd914ff7b" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">1</a><span id="df051637-4f2d-4d6c-a1f6-323bd914ff7b" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v1066785" class="anchor"></span><div class="para"> <p>Patients with <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> gene mutations should be referred to a gynecologic oncologist for counseling regarding ovarian cancer risk reduction. For these patients, risk-reducing bilateral salpingo-oophorectomy decreases the risks of ovarian and, to a lesser degree, breast cancer (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="28f965e6-980e-4e70-b33b-c212d574c688" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">2</a><span id="28f965e6-980e-4e70-b33b-c212d574c688" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="86ab5f3f-d5e6-48ea-8d64-b21f9be3d815" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">3</a><span id="86ab5f3f-d5e6-48ea-8d64-b21f9be3d815" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Use of estrogen-progestin contraceptives is not recommended as an alternative method of ovarian cancer prevention, except for patients who are not candidates for surgery or choose not to undergo surgery. </p></div><span id="v84058394" class="anchor"></span><div class="para"> <p>For patients with BRCA mutations, use of oral contraceptives has been found to be associated with a reduction in ovarian cancer risk; however, other formulations as vaginal ring, intrauterine device, or patches have not been studied, and it is unknown whether they provide similar ovarian cancer prevention. A meta-analysis including 1503 cases of ovarian cancer in women with <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutations showed a 50% reduction in ovarian cancer risk associated with oral contraceptives (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="c395dcff-724d-47b1-a81b-586e5592748f" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">4</a><span id="c395dcff-724d-47b1-a81b-586e5592748f" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>); there was no significant increase in breast cancer risk with use of current oral contraceptive formulations. A large study included in the meta-analysis (n=798 women with ovarian cancer) reported a 5% decrease in the risk of ovarian cancer per year of oral contraceptive use (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="788deb40-c144-491a-a10d-c4ec1bd2fa27" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">5</a><span id="788deb40-c144-491a-a10d-c4ec1bd2fa27" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). A large cohort study found a maximum benefit when used for 3 to 5 years (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="2c311473-e1e1-4ab1-b615-4b93ebd4677a" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">6</a><span id="2c311473-e1e1-4ab1-b615-4b93ebd4677a" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div> <section id="v68352541" class="topic__section GHead"> <span></span> <h3 id="Prevention_v1066784_v68352542" class="topic__header--subsection"> <span id="v68352542" class="anchor"></span> Screening </h3> <div class="topic__content"> <span id="v68352543" class="anchor"></span><div class="para"> <p>There is no screening test for ovarian cancer. However, women with a known hereditary risk, such as those with <i data-mmanualobjecttype='gene' '>BRCA</i> mutations, should be followed closely.</p></div><span id="v68352545" class="anchor"></span><div class="para"> <p>A meta-analysis of 51 studies found that CA 125 has a sensitivity of 79% and a specificity of 78% (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574" data-toggle="tooltip" title="Prevention references" data-id="e19d5647-e183-4e96-a4a5-b16040b59166" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">7</a><span id="e19d5647-e183-4e96-a4a5-b16040b59166" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>); thus, CA 125 is not recommended as a screening test for asymptomatic, average-risk women. </p></div><span id="v68352546" class="anchor"></span><div class="para"> <p>Multimodal screening has been studied but has not been determined to be effective. A large randomized trial compared annual multimodal screening (CA 125, transvaginal ultrasonography [TVUS]) with no screening. At a median follow-up of 16.3 years, multimodal screening detected more women with early stage ovarian or fallopian tube cancer; however, there was no significant reduction in deaths due to ovarian or fallopian tube cancer (<a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574" data-toggle="tooltip" title="Prevention references" data-id="c608b80b-9aee-4e80-8f7d-951903328281" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">8</a><span id="c608b80b-9aee-4e80-8f7d-951903328281" class="d-none xref"> <span class="tooltip-container"> <a href="./{048AD20D-932A-4CDB-81E9-4C8EA1525476}.html#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div><span id="v68352548" class="anchor"></span><div class="para"> <p>Most breast and ovarian cancers are sporadic, rather than caused by a known gene mutation; only approximately 15% of ovarian cancer cases are caused by <i data-mmanualobjecttype='gene' '>BRCA</i> mutations (<a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574" data-toggle="tooltip" title="Prevention references" data-id="fc52e548-cb2b-4cf4-b5d5-82dd33a68ce3" data-itemid="048ad20d-932a-4cdb-81e9-4c8ea1525476">9</a><span id="fc52e548-cb2b-4cf4-b5d5-82dd33a68ce3" class="d-none xref"> <span class="tooltip-container"> <a href="/professional/gynecology-and-obstetrics/gynecologic-tumors/ovarian,-fallopian-tube,-and-peritoneal-cancer#v68352574"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention references </span> Ovarian cancer is often fatal because it is usually advanced when diagnosed. The most common histology—high-grade serous epithelial ovarian cancer—is considered as a single clinical entity along... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). However, evaluation for a hereditary cancer syndrome should be considered in all women diagnosed with ovarian, fallopian tube, or peritoneal cancer, and they should have a genetic risk evaluation. A germline or somatic <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutation may affect treatment and maintenance therapy. A detailed personal and family history of other cancers should be obtained to identify women who are more likely to have a hereditary cancer syndrome (eg, one involving <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutations, Lynch syndrome [hereditary nonpolyposis colorectal cancer]).</p></div><span id="v68352554" class="anchor"></span><div class="para"> <p>Women should be screened for abnormalities in the <i data-mmanualobjecttype='gene' '>BRCA</i> gene if their family history includes any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v68352558" class="anchor"></span><div class="para"> <p>Diagnosis of ovarian cancer in a 1st-degree relative before age 40</p></div></li><li class="topic__listitem"><span id="v68352560" class="anchor"></span><div class="para"> <p>Diagnosis of breast and ovarian cancer in only one 1st-degree relative if one of the cancers was diagnosed before age 50</p></div></li><li class="topic__listitem"><span id="v68352562" class="anchor"></span><div class="para"> <p>Two cases of ovarian cancer among 1st- and 2nd-degree relatives of the same lineage</p></div></li><li class="topic__listitem"><span id="v68352564" class="anchor"></span><div class="para"> <p>Two cases of breast cancer and one case of ovarian cancer among 1st- or 2nd-degree relatives of the same lineage</p></div></li><li class="topic__listitem"><span id="v68352566" class="anchor"></span><div class="para"> <p>One case of breast and one case of ovarian cancer among 1st- or 2nd-degree relatives of the same lineage if breast cancer was diagnosed before age 40 or if ovarian cancer was diagnosed before age 50</p></div></li><li class="topic__listitem"><span id="v68352568" class="anchor"></span><div class="para"> <p>Two cases of breast cancer among 1st- or 2nd-degree relatives of the same lineage if both cases were diagnosed before age 50</p></div></li><li class="topic__listitem"><span id="v68352570" class="anchor"></span><div class="para"> <p>Two cases of breast cancer among 1st- or 2nd-degree relatives of the same lineage if one was diagnosed before age 40</p></div></li></ul></div><span id="v68352571" class="anchor"></span><div class="para"> <p>Also, if Ashkenazi Jewish women have one family member with breast cancer diagnosed before age 50 or with ovarian cancer, screening for abnormalities in the <i data-mmanualobjecttype='gene' '>BRCA</i> gene should be considered.</p></div> </div> </section> <section id="v68352573" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Prevention_v1066784_v68352574" class="topic__header--subsection"> <span itemprop="name" id="v68352574" class="anchor"></span> Prevention references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84058403" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28188769/">Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC</a>: Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. <i>Am J Obstet Gynecol</i> 216(6):580.e1-580.e9, 2017. doi:10.1016/j.ajog.2017.02.002</p></div></li><li class="topic__listitem"><span id="v84058406" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271468/">Marchetti C, De Felice F, Palaia I, et al</a>: Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. <i>BMC Womens Health</i> 14:150, 2014. Published 2014 Dec 12. doi:10.1186/s12905-014-0150-5</p></div></li><li class="topic__listitem"><span id="v84058409" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907985/">Choi YH, Terry MB, Daly MB, et al</a>: Association of risk-reducing salpingo-oophorectomy with breast cancer risk in women with BRCA1 and BRCA2 pathogenic ariants. <i>JAMA Oncol</i> 7(4):585-592, 2021. doi:10.1001/jamaoncol.2020.7995</p></div></li><li class="topic__listitem"><span id="v84058412" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/20537530/">Iodice S, Barile M, Rotmensz N, et al</a>: Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. <i>Eur J Cancer</i> 46(12):2275-2284, 2010. doi:10.1016/j.ejca.2010.04.018</p></div></li><li class="topic__listitem"><span id="v84058415" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17196508/">McLaughlin JR, Risch HA, Lubinski J, et al</a>: Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. <i>Lancet Oncol</i> 8(1):26-34, 2007. doi:10.1016/S1470-2045(06)70983-4</p></div></li><li class="topic__listitem"><span id="v84058418" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458227/">Kotsopoulos J, Lubinski J, Gronwald J, et al</a>: Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. <i>Int J Cancer</i> 137(5):1136-1146, 2015. doi:10.1002/ijc.29386</p></div></li><li class="topic__listitem"><span id="v84058421" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22484399/">Dodge JE, Covens AL, Lacchetti C, et al</a>: Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis. <i>Gynecol Oncol</i> 126(1):157-166, 2012. doi:10.1016/j.ygyno.2012.03.048</p></div></li><li class="topic__listitem"><span id="v68352577" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192829/">Menon U, Gentry-Maharaj A, Burnell M, et al </a>: Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. <i>Lancet</i> 397 (10290):2182–2193, 2021. doi: 10.1016/S0140-6736(21)00731-5 </p></div></li><li class="topic__listitem"><span id="v84058424" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/21324516/">Zhang S, Royer R, Li S, et al</a>: Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. <i>Gynecol Oncol</i> 121(2):353-357, 2011. doi:10.1016/j.ygyno.2011.01.020</p></div></li></ul></div> </div> </section> </div> </section> <section id="v8544663" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v8544664" class="topic__header--section"> <span id="v8544664" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v8544667" class="anchor"></span><div class="para"> <p>Ovarian cancer affects mostly postmenopausal and perimenopausal women; nulliparity, delayed childbearing, early menarche, delayed menopause, and certain genetic markers (<i data-mmanualobjecttype='gene' '>BRCA</i> mutations) increase risk.</p></div></li><li class="topic__listitem"><span id="v8544669" class="anchor"></span><div class="para"> <p>Symptoms (eg, dyspepsia, bloating, early satiety, gas pains, backache) are nonspecific.</p></div></li><li class="topic__listitem"><span id="v8544671" class="anchor"></span><div class="para"> <p>If cancer is suspected, do ultrasonography first (sometimes followed by CT or MRI) and measure tumor markers (eg, CA 125).</p></div></li><li class="topic__listitem"><span id="v8544676" class="anchor"></span><div class="para"> <p>Typically, treatment is surgical staging (including hysterectomy, bilateral salpingo-oophorectomy, pelvic washings, and peritoneal biopsy) and cytoreductive surgery followed by chemotherapy (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span>).</p></div></li><li class="topic__listitem"><span id="v8544673" class="anchor"></span><div class="para"> <p>Effective screening is not available for average-risk women; screen women at high risk (eg, <i data-mmanualobjecttype='gene' '>BRCA</i> mutation carriers) with ultrasonography and/or CA 125.</p></div></li></ul></div> </div> </section> <section id="v31323327" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v31323328" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v49778186" class="anchor"></span><div class="para"> <p>The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v31323331" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.cancer.gov/types/ovarian/hp">National Cancer Institute: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer</a>: This web site provides links to information about causes, genetics, prevention, and treatment of ovarian, fallopian tube, and primary peritoneal cancer, as well as links to information about screening, statistics, and supportive and palliative care.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="183.0;183.8;198.6;233.39">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '183.0;183.8;198.6;233.39',
 title: 'Ovarian, Fallopian Tube, and Peritoneal Cancer',
 itemGuid: '048ad20d-932a-4cdb-81e9-4c8ea1525476'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{AB141F77-EA01-4252-8A4D-A5D08C7A13C7}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Uterine Sarcomas</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{D96F2C92-C470-49E6-803E-7592E4C8B04C}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Gestational Trophoblastic Disease</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="2c267b78-6230-45c2-aca2-f4a53dbedfca_mobile" usemap="#2c267b78-6230-45c2-aca2-f4a53dbedfca_mobile" width="326" height="90">
 <map name="2c267b78-6230-45c2-aca2-f4a53dbedfca_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="2c267b78-6230-45c2-aca2-f4a53dbedfca_tablet" usemap="#2c267b78-6230-45c2-aca2-f4a53dbedfca_tablet" width="326" height="90">
 <map name="2c267b78-6230-45c2-aca2-f4a53dbedfca_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="2c267b78-6230-45c2-aca2-f4a53dbedfca_desktop" usemap="#2c267b78-6230-45c2-aca2-f4a53dbedfca_desktop" width="326" height="90">
 <map name="2c267b78-6230-45c2-aca2-f4a53dbedfca_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd04
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="048AD20D932A4CDB81E94C8EA1525476">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v1066612'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066614"></span> <div class="TableFullPage" id="v1066612"> <h3 class="title">FIGO Surgical Staging of Ovarian, Fallopian Tube, and Peritoneal Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256992" class="anchor"></span><div class="para"> <p>Stage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256995" class="anchor"></span><div class="para"> <p>Description</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066624" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v1066626" class="anchor"></span><div class="para"> <p>Tumor limited to the ovaries or fallopian tubes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291370" class="anchor"></span><div class="para"> <p>IA</p></div></li></ul></div></td><td><span id="v1066631" class="anchor"></span><div class="para"> <p>Tumor limited to one ovary (capsule intact) or fallopian tube; no tumor on ovarian or fallopian tube surface; no malignant cells in ascitic fluid or in peritoneal washings</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291373" class="anchor"></span><div class="para"> <p>IB</p></div></li></ul></div></td><td><span id="v1066636" class="anchor"></span><div class="para"> <p>Tumor limited to one or both ovaries (capsule intact) or fallopian tubes; no tumor on the surface of ovary or fallopian tube; no malignant cells in ascitic fluid or in peritoneal washings</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291376" class="anchor"></span><div class="para"> <p>IC</p></div></li></ul></div></td><td><span id="v1066641" class="anchor"></span><div class="para"> <p>Tumor limited to one or both ovaries or fallopian tubes, plus any of the following:</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291379" class="anchor"></span><div class="para"> <p>IC1</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323085" class="anchor"></span><div class="para"> <p>Surgical spill</p></div></li></ul></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291382" class="anchor"></span><div class="para"> <p>IC2</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323092" class="anchor"></span><div class="para"> <p>Capsule ruptured before surgery or tumor on the surface of the ovary or fallopian tube</p></div></li></ul></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291385" class="anchor"></span><div class="para"> <p>IC3</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323099" class="anchor"></span><div class="para"> <p>Malignant cells in ascitic fluid or in peritoneal washings</p></div></li></ul></div></td></tr><tr class="even"><td><span id="v1066644" class="anchor"></span><div class="para"> <p>II</p></div></td><td><span id="v1066646" class="anchor"></span><div class="para"> <p>Tumor involving one or both ovaries or fallopian tubes with pelvic extension (below pelvic brim) or peritoneal cancer</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291388" class="anchor"></span><div class="para"> <p>IIA</p></div></li></ul></div></td><td><span id="v1066651" class="anchor"></span><div class="para"> <p>Extension and/or implants on the uterus, fallopian tubes, and/or ovaries</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291391" class="anchor"></span><div class="para"> <p>IIB</p></div></li></ul></div></td><td><span id="v1066656" class="anchor"></span><div class="para"> <p>Extension and/or implants on other pelvic intraperitoneal tissues</p></div></td></tr><tr class="odd"><td><span id="v1066664" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v1066666" class="anchor"></span><div class="para"> <p>Tumor involving one or both ovaries or fallopian tubes or peritoneal cancer with microscopically confirmed peritoneal metastases outside the pelvis and/or metastasis to the retroperitoneal lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291397" class="anchor"></span><div class="para"> <p>IIIA1</p></div></li></ul></div></td><td><span id="v31323104" class="anchor"></span><div class="para"> <p>Positive retroperitoneal lymph nodes only (histologically proved)</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291400" class="anchor"></span><div class="para"> <p>IIIA1(i)</p></div></li></ul></div></td><td><span id="v31323109" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Metastasis ≤ 10 mm in largest dimension</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291403" class="anchor"></span><div class="para"> <p>IIIA1(ii)</p></div></li></ul></div></td><td><span id="v31323114" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Metastasis > 10 mm in largest dimension</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291406" class="anchor"></span><div class="para"> <p>IIIA2</p></div></li></ul></div></td><td><span id="v31323119" class="anchor"></span><div class="para"> <p>Microscopic extrapelvic (beyond the pelvic brim) peritoneal involvement, with or without positive retroperitoneal lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291409" class="anchor"></span><div class="para"> <p>IIIB</p></div></li></ul></div></td><td><span id="v1066676" class="anchor"></span><div class="para"> <p>Macroscopic peritoneal metastases that extend beyond the pelvis and that are <span class='symbol'>≤</span> 2 cm in largest dimension, with or without positive retroperitoneal lymph nodes</p></div></td></tr><tr class="odd"><td><span id="v1066679" class="anchor"></span><div class="para"> <p style='padding-left:12px'>IIIC</p></div></td><td><span id="v1066681" class="anchor"></span><div class="para"> <p>Macroscopic peritoneal metastases that extend beyond the pelvis and are <span class='symbol'>></span> 2 cm in largest dimension, with or without metastasis to retroperitoneal lymph nodes (includes extension of tumor to the capsule of the liver and spleen without parenchymal involvement of either organ)</p></div></td></tr><tr class="even"><td><span id="v1066684" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v1066686" class="anchor"></span><div class="para"> <p>Distant metastases excluding peritoneal metastases</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291415" class="anchor"></span><div class="para"> <p>IVA</p></div></li></ul></div></td><td><span id="v31323124" class="anchor"></span><div class="para"> <p>Pleural effusion with positive cytology</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291418" class="anchor"></span><div class="para"> <p>IVB</p></div></li></ul></div></td><td><span id="v31323129" class="anchor"></span><div class="para"> <p>Parenchymal metastasis and/or metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity)</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v42291366" class="anchor"></span><div class="para"> <p>Adapted from staging established by the International Federation of Gynecology and Obstetrics (FIGO): <a rel="nofollow" target="_blank" href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.13878">Berek JS, Renz M, Kehoe S,et al</a>: Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. <i>Int J Gynaecol Obstet</i> 155 Suppl 1:61–85, 2021. doi: 10.1002/ijgo.13878</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v68351666'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v68351667"></span> <div class="TableFullPage" id="v68351666"> <h3 class="title">Postoperative Treatment of Ovarian Cancer by Stage and Type</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v68351682" class="anchor"></span><div class="para"> <p>Stage and Type</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v68351687" class="anchor"></span><div class="para"> <p>Treatment*</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v68351702" class="anchor"></span><div class="para"> <p>Stage IA or B/grade 1 epithelial adenocarcinoma</p></div></td><td><span id="v68351704" class="anchor"></span><div class="para"> <p>No postoperative therapy</p></div></td></tr><tr class="even"><td><span id="v68351707" class="anchor"></span><div class="para"> <p>Stage IA or B/grade 2 or 3 cancers</p></div><span id="v68351708" class="anchor"></span><div class="para"> <p>Stage II cancer</p></div></td><td><span id="v68351710" class="anchor"></span><div class="para"> <p>6 courses of chemotherapy (typically, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>)</p></div></td></tr><tr class="odd"><td><span id="v68351713" class="anchor"></span><div class="para"> <p>Stage III cancer</p></div></td><td><span id="v68351715" class="anchor"></span><div class="para"> <p>6 courses of chemotherapy† as for stage IA or B/grade 2 or 3</p></div><span id="v68351716" class="anchor"></span><div class="para"> <p>Consideration of intraperitoneal <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></td></tr><tr class="even"><td><span id="v68351719" class="anchor"></span><div class="para"> <p>Stage IV cancer</p></div></td><td><span id="v68351721" class="anchor"></span><div class="para"> <p>Infrequently, radiation therapy</p></div></td></tr><tr class="odd"><td><span id="v68351724" class="anchor"></span><div class="para"> <p>Germ cell tumors</p></div><span id="v68351725" class="anchor"></span><div class="para"> <p>Stage II or III stromal tumors</p></div></td><td><span id="v68351727" class="anchor"></span><div class="para"> <p>Most often, combination chemotherapy, usually <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bleomycin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>etoposide</span></p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v68351691" class="anchor"></span><div class="para"> <p>* Maintenance therapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span> or a PARP inhibitor is given to some patients with <i data-mmanualobjecttype='gene' '="">BRCA</i> mutations or homologous recombination deficiency.</p></div></td></tr><tr><td colspan="2"><span id="v68351695" class="anchor"></span><div class="para"> <p>† Intraperitoneal chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> results in longer survival than IV chemotherapy but may have a higher complication rate.</p></div></td></tr><tr><td colspan="2"><span id="v68351698" class="anchor"></span><div class="para"> <p>PARP = polyadenosine diphosphate-ribose polymerase.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v1066507'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066509"></span> <div class="TableFullPage" id="v1066507"> <h3 class="title">Types of Ovarian Cancers</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256915" class="anchor"></span><div class="para"> <p>Origin</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256918" class="anchor"></span><div class="para"> <p>Types</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066519" class="anchor"></span><div class="para"> <p>Epithelium</p></div></td><td><span id="v1066521" class="anchor"></span><div class="para"> <p>Brenner tumor</p></div><span id="v1066522" class="anchor"></span><div class="para"> <p>Clear cell carcinomas</p></div><span id="v1066523" class="anchor"></span><div class="para"> <p>Endometrioid carcinomas</p></div><span id="v1066524" class="anchor"></span><div class="para"> <p>Mucinous carcinomas</p></div><span id="v1066525" class="anchor"></span><div class="para"> <p>Serous cystadenocarcinomas (most common overall)</p></div><span id="v1066526" class="anchor"></span><div class="para"> <p>Transitional cell carcinomas</p></div><span id="v1066527" class="anchor"></span><div class="para"> <p>Unclassified carcinomas</p></div></td></tr><tr class="even"><td><span id="v1066530" class="anchor"></span><div class="para"> <p>Primary germ cells</p></div></td><td><span id="v1066532" class="anchor"></span><div class="para"> <p>Choriocarcinomas</p></div><span id="v1066533" class="anchor"></span><div class="para"> <p>Dysgerminomas</p></div><span id="v1066534" class="anchor"></span><div class="para"> <p>Embryonal carcinomas</p></div><span id="v1066535" class="anchor"></span><div class="para"> <p>Endodermal sinus tumors</p></div><span id="v1066536" class="anchor"></span><div class="para"> <p>Immature teratomas</p></div><span id="v1066537" class="anchor"></span><div class="para"> <p>Polyembryoma</p></div></td></tr><tr class="odd"><td><span id="v1066540" class="anchor"></span><div class="para"> <p>Sex cord and stromal cells</p></div></td><td><span id="v1066542" class="anchor"></span><div class="para"> <p>Granulosa-theca cell tumors</p></div><span id="v1066543" class="anchor"></span><div class="para"> <p>Sertoli-Leydig cell tumors</p></div></td></tr><tr class="even"><td><span id="v1066546" class="anchor"></span><div class="para"> <p>Metastases</p></div></td><td><span id="v1066548" class="anchor"></span><div class="para"> <p>Breast cancer</p></div><span id="v1066549" class="anchor"></span><div class="para"> <p>Cancer of the gastrointestinal tract</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1066507'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066509"></span> <div class="TableFullPage" id="v1066507"> <h3 class="title">Types of Ovarian Cancers</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256915" class="anchor"></span><div class="para"> <p>Origin</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256918" class="anchor"></span><div class="para"> <p>Types</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066519" class="anchor"></span><div class="para"> <p>Epithelium</p></div></td><td><span id="v1066521" class="anchor"></span><div class="para"> <p>Brenner tumor</p></div><span id="v1066522" class="anchor"></span><div class="para"> <p>Clear cell carcinomas</p></div><span id="v1066523" class="anchor"></span><div class="para"> <p>Endometrioid carcinomas</p></div><span id="v1066524" class="anchor"></span><div class="para"> <p>Mucinous carcinomas</p></div><span id="v1066525" class="anchor"></span><div class="para"> <p>Serous cystadenocarcinomas (most common overall)</p></div><span id="v1066526" class="anchor"></span><div class="para"> <p>Transitional cell carcinomas</p></div><span id="v1066527" class="anchor"></span><div class="para"> <p>Unclassified carcinomas</p></div></td></tr><tr class="even"><td><span id="v1066530" class="anchor"></span><div class="para"> <p>Primary germ cells</p></div></td><td><span id="v1066532" class="anchor"></span><div class="para"> <p>Choriocarcinomas</p></div><span id="v1066533" class="anchor"></span><div class="para"> <p>Dysgerminomas</p></div><span id="v1066534" class="anchor"></span><div class="para"> <p>Embryonal carcinomas</p></div><span id="v1066535" class="anchor"></span><div class="para"> <p>Endodermal sinus tumors</p></div><span id="v1066536" class="anchor"></span><div class="para"> <p>Immature teratomas</p></div><span id="v1066537" class="anchor"></span><div class="para"> <p>Polyembryoma</p></div></td></tr><tr class="odd"><td><span id="v1066540" class="anchor"></span><div class="para"> <p>Sex cord and stromal cells</p></div></td><td><span id="v1066542" class="anchor"></span><div class="para"> <p>Granulosa-theca cell tumors</p></div><span id="v1066543" class="anchor"></span><div class="para"> <p>Sertoli-Leydig cell tumors</p></div></td></tr><tr class="even"><td><span id="v1066546" class="anchor"></span><div class="para"> <p>Metastases</p></div></td><td><span id="v1066548" class="anchor"></span><div class="para"> <p>Breast cancer</p></div><span id="v1066549" class="anchor"></span><div class="para"> <p>Cancer of the gastrointestinal tract</p></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v1066612'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066614"></span> <div class="TableFullPage" id="v1066612"> <h3 class="title">FIGO Surgical Staging of Ovarian, Fallopian Tube, and Peritoneal Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256992" class="anchor"></span><div class="para"> <p>Stage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v1256995" class="anchor"></span><div class="para"> <p>Description</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v1066624" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v1066626" class="anchor"></span><div class="para"> <p>Tumor limited to the ovaries or fallopian tubes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291370" class="anchor"></span><div class="para"> <p>IA</p></div></li></ul></div></td><td><span id="v1066631" class="anchor"></span><div class="para"> <p>Tumor limited to one ovary (capsule intact) or fallopian tube; no tumor on ovarian or fallopian tube surface; no malignant cells in ascitic fluid or in peritoneal washings</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291373" class="anchor"></span><div class="para"> <p>IB</p></div></li></ul></div></td><td><span id="v1066636" class="anchor"></span><div class="para"> <p>Tumor limited to one or both ovaries (capsule intact) or fallopian tubes; no tumor on the surface of ovary or fallopian tube; no malignant cells in ascitic fluid or in peritoneal washings</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291376" class="anchor"></span><div class="para"> <p>IC</p></div></li></ul></div></td><td><span id="v1066641" class="anchor"></span><div class="para"> <p>Tumor limited to one or both ovaries or fallopian tubes, plus any of the following:</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291379" class="anchor"></span><div class="para"> <p>IC1</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323085" class="anchor"></span><div class="para"> <p>Surgical spill</p></div></li></ul></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291382" class="anchor"></span><div class="para"> <p>IC2</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323092" class="anchor"></span><div class="para"> <p>Capsule ruptured before surgery or tumor on the surface of the ovary or fallopian tube</p></div></li></ul></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291385" class="anchor"></span><div class="para"> <p>IC3</p></div></li></ul></div></td><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v31323099" class="anchor"></span><div class="para"> <p>Malignant cells in ascitic fluid or in peritoneal washings</p></div></li></ul></div></td></tr><tr class="even"><td><span id="v1066644" class="anchor"></span><div class="para"> <p>II</p></div></td><td><span id="v1066646" class="anchor"></span><div class="para"> <p>Tumor involving one or both ovaries or fallopian tubes with pelvic extension (below pelvic brim) or peritoneal cancer</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291388" class="anchor"></span><div class="para"> <p>IIA</p></div></li></ul></div></td><td><span id="v1066651" class="anchor"></span><div class="para"> <p>Extension and/or implants on the uterus, fallopian tubes, and/or ovaries</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291391" class="anchor"></span><div class="para"> <p>IIB</p></div></li></ul></div></td><td><span id="v1066656" class="anchor"></span><div class="para"> <p>Extension and/or implants on other pelvic intraperitoneal tissues</p></div></td></tr><tr class="odd"><td><span id="v1066664" class="anchor"></span><div class="para"> <p>III</p></div></td><td><span id="v1066666" class="anchor"></span><div class="para"> <p>Tumor involving one or both ovaries or fallopian tubes or peritoneal cancer with microscopically confirmed peritoneal metastases outside the pelvis and/or metastasis to the retroperitoneal lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291397" class="anchor"></span><div class="para"> <p>IIIA1</p></div></li></ul></div></td><td><span id="v31323104" class="anchor"></span><div class="para"> <p>Positive retroperitoneal lymph nodes only (histologically proved)</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291400" class="anchor"></span><div class="para"> <p>IIIA1(i)</p></div></li></ul></div></td><td><span id="v31323109" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Metastasis ≤ 10 mm in largest dimension</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291403" class="anchor"></span><div class="para"> <p>IIIA1(ii)</p></div></li></ul></div></td><td><span id="v31323114" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Metastasis > 10 mm in largest dimension</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291406" class="anchor"></span><div class="para"> <p>IIIA2</p></div></li></ul></div></td><td><span id="v31323119" class="anchor"></span><div class="para"> <p>Microscopic extrapelvic (beyond the pelvic brim) peritoneal involvement, with or without positive retroperitoneal lymph nodes</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291409" class="anchor"></span><div class="para"> <p>IIIB</p></div></li></ul></div></td><td><span id="v1066676" class="anchor"></span><div class="para"> <p>Macroscopic peritoneal metastases that extend beyond the pelvis and that are <span class='symbol'>≤</span> 2 cm in largest dimension, with or without positive retroperitoneal lymph nodes</p></div></td></tr><tr class="odd"><td><span id="v1066679" class="anchor"></span><div class="para"> <p style='padding-left:12px'>IIIC</p></div></td><td><span id="v1066681" class="anchor"></span><div class="para"> <p>Macroscopic peritoneal metastases that extend beyond the pelvis and are <span class='symbol'>></span> 2 cm in largest dimension, with or without metastasis to retroperitoneal lymph nodes (includes extension of tumor to the capsule of the liver and spleen without parenchymal involvement of either organ)</p></div></td></tr><tr class="even"><td><span id="v1066684" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v1066686" class="anchor"></span><div class="para"> <p>Distant metastases excluding peritoneal metastases</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291415" class="anchor"></span><div class="para"> <p>IVA</p></div></li></ul></div></td><td><span id="v31323124" class="anchor"></span><div class="para"> <p>Pleural effusion with positive cytology</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v42291418" class="anchor"></span><div class="para"> <p>IVB</p></div></li></ul></div></td><td><span id="v31323129" class="anchor"></span><div class="para"> <p>Parenchymal metastasis and/or metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity)</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v42291366" class="anchor"></span><div class="para"> <p>Adapted from staging established by the International Federation of Gynecology and Obstetrics (FIGO): <a rel="nofollow" target="_blank" href="https://obgyn.onlinelibrary.wiley.com/doi/10.1002/ijgo.13878">Berek JS, Renz M, Kehoe S,et al</a>: Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. <i>Int J Gynaecol Obstet</i> 155 Suppl 1:61–85, 2021. doi: 10.1002/ijgo.13878</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v68351666'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v68351667"></span> <div class="TableFullPage" id="v68351666"> <h3 class="title">Postoperative Treatment of Ovarian Cancer by Stage and Type</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v68351682" class="anchor"></span><div class="para"> <p>Stage and Type</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v68351687" class="anchor"></span><div class="para"> <p>Treatment*</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v68351702" class="anchor"></span><div class="para"> <p>Stage IA or B/grade 1 epithelial adenocarcinoma</p></div></td><td><span id="v68351704" class="anchor"></span><div class="para"> <p>No postoperative therapy</p></div></td></tr><tr class="even"><td><span id="v68351707" class="anchor"></span><div class="para"> <p>Stage IA or B/grade 2 or 3 cancers</p></div><span id="v68351708" class="anchor"></span><div class="para"> <p>Stage II cancer</p></div></td><td><span id="v68351710" class="anchor"></span><div class="para"> <p>6 courses of chemotherapy (typically, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>carboplatin</span>)</p></div></td></tr><tr class="odd"><td><span id="v68351713" class="anchor"></span><div class="para"> <p>Stage III cancer</p></div></td><td><span id="v68351715" class="anchor"></span><div class="para"> <p>6 courses of chemotherapy† as for stage IA or B/grade 2 or 3</p></div><span id="v68351716" class="anchor"></span><div class="para"> <p>Consideration of intraperitoneal <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span></p></div></td></tr><tr class="even"><td><span id="v68351719" class="anchor"></span><div class="para"> <p>Stage IV cancer</p></div></td><td><span id="v68351721" class="anchor"></span><div class="para"> <p>Infrequently, radiation therapy</p></div></td></tr><tr class="odd"><td><span id="v68351724" class="anchor"></span><div class="para"> <p>Germ cell tumors</p></div><span id="v68351725" class="anchor"></span><div class="para"> <p>Stage II or III stromal tumors</p></div></td><td><span id="v68351727" class="anchor"></span><div class="para"> <p>Most often, combination chemotherapy, usually <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bleomycin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>etoposide</span></p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v68351691" class="anchor"></span><div class="para"> <p>* Maintenance therapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bevacizumab</span> or a PARP inhibitor is given to some patients with <i data-mmanualobjecttype='gene' '="">BRCA</i> mutations or homologous recombination deficiency.</p></div></td></tr><tr><td colspan="2"><span id="v68351695" class="anchor"></span><div class="para"> <p>† Intraperitoneal chemotherapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cisplatin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> results in longer survival than IV chemotherapy but may have a higher complication rate.</p></div></td></tr><tr><td colspan="2"><span id="v68351698" class="anchor"></span><div class="para"> <p>PARP = polyadenosine diphosphate-ribose polymerase.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>